Submission Details
| 510(k) Number | K192922 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 16, 2019 |
| Decision Date | February 20, 2020 |
| Days to Decision | 127 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K192922 is an FDA 510(k) clearance for the Gentuity HF-OCT Imaging System with Vis-Rx Micro-Imaging Catheter, a System, Imaging, Optical Coherence Tomography (oct) (Class II — Special Controls, product code NQQ), submitted by Gentuity, LLC (Sudbury, US). The FDA issued a Cleared decision on February 20, 2020, 127 days after receiving the submission on October 16, 2019. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 892.1560.
| 510(k) Number | K192922 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | October 16, 2019 |
| Decision Date | February 20, 2020 |
| Days to Decision | 127 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | NQQ — System, Imaging, Optical Coherence Tomography (oct) |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 892.1560 |
| Definition | This Device Uses Back-reflected Light To Create Two-dimensional Images Versus Back-reflected Sound Waves As Are Used In Ultrasound Imaging. |